Cargando…
MicroRNA-33b is a Potential Non-Invasive Biomarker for Response to Atorvastatin Treatment in Chilean Subjects With Hypercholesterolemia: A Pilot Study
Evidence accumulated so far indicates that circulating levels of microRNAs (miRNAs) are associated with several pathologies. Therefore, differential expression of extracellular miRNAs exhibits promising potential for screening and diagnosis purposes. We evaluated plasma miRNAs in response to the lip...
Autores principales: | Ubilla, Carmen Gloria, Prado, Yalena, Angulo, Jeremy, Obreque, Ignacio, Paez, Isis, Saavedra, Nicolás, Saavedra, Kathleen, Zambrano, Tomás, Salazar, Luis A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175777/ https://www.ncbi.nlm.nih.gov/pubmed/34093203 http://dx.doi.org/10.3389/fphar.2021.674252 |
Ejemplares similares
-
Cholesterol-Related lncRNAs as Response Predictors of Atorvastatin Treatment in Chilean Hypercholesterolemic Patients: A Pilot Study
por: Paez, Isis, et al.
Publicado: (2023) -
Atorvastatin Increases the Expression of Long Non-Coding RNAs ARSR and CHROME in Hypercholesterolemic Patients: A Pilot Study
por: Paez, Isis, et al.
Publicado: (2020) -
MicroRNA-20a-5p Downregulation by Atorvastatin: A Potential Mechanism Involved in Lipid-Lowering Therapy
por: Saavedra, Kathleen, et al.
Publicado: (2022) -
SLCO1B1 c.388A>G Polymorphism Is Associated with HDL-C Levels in Response to Atorvastatin in Chilean Individuals
por: Prado, Yalena, et al.
Publicado: (2015) -
APOE Polymorphisms Contribute to Reduced Atorvastatin Response in Chilean Amerindian Subjects
por: Lagos, Jenny, et al.
Publicado: (2015)